Skip to main content

Table 1 Input parameters used in in silico ciprofloxacin and levofloxacin dosing trials in PIRRT [3036]

From: In silico trials using Monte Carlo simulation to evaluate ciprofloxacin and levofloxacin dosing in critically ill patients receiving prolonged intermittent renal replacement therapy

 

Ciprofloxacin

Levofloxacin

Demographic and pharmacokinetic parameters

Weight (kg)

86.6 ± 29.2 [≥40]

Volume of distribution (L/kg)

1.25 ± 0.4 [0.5–1.92]

1.2 ± 0.4 [0.7–2.08]

Non-renal clearance (mL/min)

116 ± 61 [13–259]

25.7 ± 14 [0.12–67]

Saturation/sieving coefficient

0.7 ± 0.2 [0–1]

0.6 ± 0.2 [0–1]

PIRRT operation parameters

Modality

Hemofiltration or hemodialysis

Frequency

Daily

Blood flow rate

300 mL/min

Dialysate/ultrafiltration flow rate and duration

4 L/h for 10 h or 5 L/h for 8 h

  1. All values are represented as mean ± SD [assigned model limits]